MenoRelief is a comprehensive, multi-system menopause relief formula designed to help reduce symptoms of menopause, support sexual health, promote healthy mood balance, and reduce cortisol levels—a biomarker of physical stress. It combines standardized Affron® saffron extract with MS-10™ (Korean thistle & thyme) and passionflower for multi-system support.
Evidence Snapshot
Affron® saffron (Crocus sativus) is standardized to ≥3.5% bioactives (crocin isomers and safranal). Clinical trials in adults andperimenopausal women show improvements in depressive symptoms, anxiety, sleep quality, and psychological domains of the GCS.
MS-10™ Korean thistle (Cirsium japonicum) & thyme (Thymus vulgaris) complex demonstrated significant reductions in total menopausal symptoms (Kupperman Index) and improvements in MENQOL domains over 12 weeks, with additional signals for reduced cortisol and improved IGF-1 in a randomized trial.
Passionflower (Passiflora incarnata) is traditionally used as a calmative, and sleep aid during times of mental stress and shows anxiolytic effects with fewer cognitive side effects versus benzodiazepines in several RCTs.
EACH CAPSULE CONTAINS:
Affron® Saffron (Crocus sativus) Stigma Std. Extract (3:1) . . . . . . . . . . . . . . 14 mg (42 mg dried equivalent, 3.48 % Crocin, 0.03 % Safranal)
MS-10™ Thistle & Thyme Extract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150 mg
Cirsium japonicum Whole plant Extract (25:1) . . . . . . . . . . . . . . . . . . . . 41.25 mg (1031.25 mg dried equivalent)
Thymus vulgaris Leaf Extract (25:1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33.75 mg (843.75 mg dried equivalent)
Passionflower (Passiflora incarnata) Herb Top Extract (4 - 6 : 1) . . . . . . . . . 50 mg (200-300 mg dried equivalent)
Non-Medicinal Ingredients: Maltodextrin, hypromellose, cellulose, magnesium stearate, gellan gum.
Recommended Dose: Adult women (18 years and older): Take 1 capsule 2 times daily, or as recommended by your healthcare practitioner. Consult a healthcare practitioner for use beyond 12 weeks.
MenoRelief is a comprehensive, multi-system menopause relief formula designed to help reduce symptoms of menopause, support sexual health, promote healthy mood balance, and reduce cortisol levels—a biomarker of physical stress. It combines standardized Affron® saffron extract with MS-10™ (Korean thistle & thyme) and passionflower for multi-system support.
Evidence Snapshot
Affron® saffron (Crocus sativus) is standardized to ≥3.5% bioactives (crocin isomers and safranal). Clinical trials in adults andperimenopausal women show improvements in depressive symptoms, anxiety, sleep quality, and psychological domains of the GCS.
MS-10™ Korean thistle (Cirsium japonicum) & thyme (Thymus vulgaris) complex demonstrated significant reductions in total menopausal symptoms (Kupperman Index) and improvements in MENQOL domains over 12 weeks, with additional signals for reduced cortisol and improved IGF-1 in a randomized trial.
Passionflower (Passiflora incarnata) is traditionally used as a calmative, and sleep aid during times of mental stress and shows anxiolytic effects with fewer cognitive side effects versus benzodiazepines in several RCTs.
EACH CAPSULE CONTAINS:
Affron® Saffron (Crocus sativus) Stigma Std. Extract (3:1) . . . . . . . . . . . . . . 14 mg (42 mg dried equivalent, 3.48 % Crocin, 0.03 % Safranal)
MS-10™ Thistle & Thyme Extract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150 mg
Cirsium japonicum Whole plant Extract (25:1) . . . . . . . . . . . . . . . . . . . . 41.25 mg (1031.25 mg dried equivalent)
Thymus vulgaris Leaf Extract (25:1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33.75 mg (843.75 mg dried equivalent)
Passionflower (Passiflora incarnata) Herb Top Extract (4 - 6 : 1) . . . . . . . . . 50 mg (200-300 mg dried equivalent)
Non-Medicinal Ingredients: Maltodextrin, hypromellose, cellulose, magnesium stearate, gellan gum.
Recommended Dose: Adult women (18 years and older): Take 1 capsule 2 times daily, or as recommended by your healthcare practitioner. Consult a healthcare practitioner for use beyond 12 weeks.
